COVID-19 BILAN KASALLANGAN SURUNKALI BUYRAK KASALLIGI BOR BEMORLARDA KOAGULYATSION GEMOSTAZDA O‘ZGARISHLAR
Abstract
COVID-19 pandemiyasi global sog‘liqni saqlash tizimiga katta tahdid solib, ayniqsa surunkali kasalliklarga ega bemorlarda og‘ir klinik kechishlar va yuqori o‘lim darajasi bilan tavsiflanadi. Surunkali buyrak kasalligi (SBK) bo‘lgan bemorlar immun tizimining zaifligi, ko‘p dori vositalarini qabul qilishi va qon ivish tizimidagi buzilishlarga moyilligi sababli xavf guruhiga kiradi.
References
Guan W, Ni Z, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829–838.
Vaziri ND, Pahl MV, Crum A, Norris K. Effect of uremia on structure and function of immune system. J Ren Nutr. 2012;22(1):149–156.
Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6): e438–e440.
Suh YJ, Hong H, Ohana M, et al. Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis. Radiology. 2021;298(2):E70–E80.
Published
Issue
Section
How to Cite
